Alvotech (ALVO) Other Non-Current Assets (2020 - 2026)
Alvotech (ALVO) posted Other Non-Current Assets of $15.0 million for Q1 2026, up 74.36% on a QoQ basis from $8.6 million in Q4 2025, and up 313.75% year-over-year from $3.6 million in Q1 2025.
Alvotech (ALVO) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alvotech's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $15.0 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 313.75% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (up 313.75% YoY) and the FY2025 annual result came in at $8.6 million, down 62.23% from the prior year.
- Other Non-Current Assets was $15.0 million for Q1 2026 at Alvotech, up from $8.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $26.1 million in Q4 2023 and bottomed at $3.6 million in Q1 2025.
- A 5-year average of $17.5 million and a median of $23.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets sank 85.54% — and 2026, when it jumped 313.75%.
- Alvotech's Other Non-Current Assets stood at $25.2 million in 2022, then climbed by 3.75% to $26.1 million in 2023, then declined by 13.1% to $22.7 million in 2024, then plunged by 62.23% to $8.6 million in 2025, then jumped by 74.36% to $15.0 million in 2026.
- Business Quant data shows ALVO's Other Non-Current Assets at $15.0 million in Q1 2026, $8.6 million in Q4 2025, and $4.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 14.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 8.58 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 22.71 Mn |
| Sep 30, 2024 | 9.52 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Mar 31, 2024 | 25.00 Mn |
| Dec 31, 2023 | 26.13 Mn |
| Jun 30, 2023 | 25.19 Mn |
| Mar 31, 2023 | 25.19 Mn |
| Dec 31, 2022 | 25.19 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Dec 31, 2021 | 10.09 Mn |
| Dec 31, 2020 | 10.09 Mn |